Microcirculatory effects of angiotensin II inhibitors in patients with severe heart failure

Clinical Hemorheology and Microcirculation

Volumn 54, Issue 1, 2013, Pages 87-98

  Salgado, Diamantino Ribeiro ^a,b   Favory, Raphaël ^a,c   Rocco, José Rodolfo ^b   Silva, Eliézer ^d,e   Ortiz, Julian Arias ^a,f   Donadello, Katia ^a   Creteur, Jacques ^a   Vincent, Jean Louis ^a   De Backer, Daniel ^a  

^a ERASME HOSPITAL   (Belgium)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

angiotensin II; angiotensin converting enzyme antagonists; critically ill; Heart failure; rennin

Indexed keywords

ANGIOTENSIN II ANTAGONIST; CAPTOPRIL; LOSARTAN; PERINDOPRIL;

ADULT; AGED; ARTICLE; BLOOD FLOW; CARDIAC PATIENT; CLINICAL ARTICLE; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART INDEX; HEART OUTPUT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MALE; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; MICROVASCULARIZATION; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SUBLINGUAL GLAND; TISSUE PERFUSION; VENOUS OXYGEN TENSION;

AGED; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; FEMALE; HEART FAILURE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PROSPECTIVE STUDIES; RENIN-ANGIOTENSIN SYSTEM;

EID: 84878893588     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1569     Document Type: Article

References (37)

1. K. F. Jr Adams, Pathophysiologic role of the renin-angiotensin- aldosterone and sympathetic nervous systems in heart failure, Am J Health Syst Pharm 61(Suppl 2) (2004), S4-S13.
2. U. M. Becher, C. Endtmann, V. Tiyerili, G. Nickenig and N. Werner, Endothelial damage and regeneration: The role of the renin-angiotensin- aldosterone system, Curr Hypertens Rep 13 (2011), 86-92.
3. D. Chen, C. Assad-Kottner, C. Orrego and G. Torre-Amione, Cytokines and acute heart failure, Crit Care Med 36 (2008), S9-S16.
4. G. Cicco, V. Fanelli, S. Cicco, M. Iacoviello and S. Favale, Could dilated cardiomyopathy alter the peripheral microcirculation and blood rheology? Adv Exp Med Biol 662 (2010), 41-47.
5. O. Dar and M. R. Cowie, Acute heart failure in the intensive care unit: Epidemiology, Crit Care Med 36 (2008), S3-S8.
6. D. De Backer, J. Creteur, M. J. Dubois, Y. Sakr and J. L. Vincent, Microvascular alterations in patients with acute severe heart failure and cardiogenic shock, Am Heart J 147 (2004), 91-99.
7. D. De Backer, J. Creteur, J. C. Preiser, M. J. Dubois and J. L. Vincent, Microvascular blood flow is altered in patients with sepsis, Am J Respir Crit Care Med 166 (2002), 98-104.
8. D. De Backer, S. Hollenberg, C. Boerma, P. Goedhart, G. Buchele, G. Ospina-Tascon, I. Dobbe and C. Ince, How to evaluate the microcirculation: Report of a round table conference, Crit Care 2007 (1), R101.
9. F. De Lorenzo, N. Saba and V. V. Kakkar, Blood coagulation in patients with chronic heart failure: Evidence for hypercoagulable state and potential for pharmacological intervention, Drugs 63 (2003), 565-576.
10. C. A. den Uil, W. K. Lagrand, S. D. Valk, P. E. Spronk and M. L. Simoons, Management of cardiogenic shock: Focus on tissue perfusion, Curr Probl Cardiol 34 (2009), 330-349.
11. C. A. den Uil, W. K. Lagrand, E. M. van der, L. S. Jewbali, J. M. Cheng, P. E. Spronk and M. L. Simoons, Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock, Eur Heart J 31 (2010), 3032-3039.
12. D. A. Duprez, Angiotensin II, platelets and oxidative stress, J Hypertens 22 (2004), 1085-1086.
13. M. Fornal, R. A. Korbut, J. Krolczyk and T. Grodzicki, Left ventricular geometry and rheological properties of erythrocytes in patients at cardiovascular disease risk, Clin Hemorheol Microcirc 43 (2009), 203-208.
14. H. Freise, D. Palmes and H. U. Spiegel, Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor, J Surg Res 134 (2006), 231-237.
15. S. Galatius, H. Wroblewski, V. Sorensen, S. Haunso, T. Norgaard and J. Kastrup, Reversal of peripheral microvascular dysfunction during long-term treatment with the angiotensin-converting enzyme inhibitor fosinopril in congestive heart failure, J Card Fail 5 (1999), 17-24.
16. C. G. Gustavsson, S. U. Persson, H. Larsson and S. Persson, Changed blood rheology in patients with idiopathic dilated cardiomyopathy, Angiology 45 (1994), 107-111.
17. E. Haak, T. Haak, K. Kusterer, B. Reschke, H. Faust and K. H. Usadel, Microcirculation in hyperglycemic patients with IDDM without diabetic complications-effect of low-dose angiotensin-converting enzyme inhibition, Exp Clin Endocrinol Diabetes 106 (1998), 45-50.
18. S. A. Hunt,W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, J. A. Oates, P. S. Rahko, M. A. Silver, L. W. Stevenson and C. W. Yancy, 2009 focused update incorporated into the ACC/AHA2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults:Areport of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation, Circulation 119 (2009), e391-e479.
19. A. M. Jonk, A. J. Houben, N. C. Schaper, P. W. de Leeuw, E. H. Serne, Y. M. Smulders and C. D. Stehouwer, Acute angiotensin II receptor blockade improves insulin-induced microvascular function in hypertensive individuals, Microvasc Res 82 (2011), 77-83.
20. C. Jung, M. Ferrari, C. Rodiger, M. Fritzenwanger and H. R. Figulla, Combined Impella and intra-aortic balloon pump support to improve macro-and microcirculation: A clinical case, Clin Res Cardiol 97 (2008), 849-850.
21. W. A. Knaus, E. A. Draper, D. P. Wagner and J. E. Zimmerman, APACHE II: A severity of disease classification system, Crit Care Med 13 (1985), 818-829.
22. A. Lauten, M. Ferrari, B. Goebel,W. Rademacher, J. Schumm, O. Uth, M. Kiehntopf, H. R. Figulla and C. Jung, Microvascular tissue perfusion is impaired in acutely decompensated heart failure and improves following standard treatment, Eur J Heart Fail 13 (2011), 711-717.
23. D. Lloyd-Jones, R. J. Adams, T. M. Brown, M. Carnethon, S. Dai, G. De Simone, T. B. Ferguson, E. Ford, K. Furie, C. Gillespie, A. Go, K. Greenlund, N. Haase, S. Hailpern, P. M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, L. Lisabeth, A. Marelli, M. M. McDermott, J. Meigs, D. Mozaffarian, M. Mussolino, G. Nichol, V. L. Roger, W. Rosamond, R. Sacco, P. Sorlie, R. Stafford, T. Thom, S. Wasserthiel-Smoller, N. D. Wong and J. Wylie-Rosett, Heart disease and stroke statistics-2010 update: A report from the American Heart Association, Circulation 121 (2010), e46-e215.
24. C. J. Lockhart, P. K. Hamilton, C. E. Quinn and G. E. McVeigh, End-organ dysfunction and cardiovascular outcomes: The role of the microcirculation, Clin Sci (Lond) 116 (2009), 175-190.
25. R. C. Parish and J. D. Evans, Inflammation in chronic heart failure, Ann Pharmacother 42 (2008), 1002-1016.
26. L. Piqueras, P. Kubes, A. Alvarez, E. O'Connor, A. C. Issekutz, J. V. Esplugues and M. J. Sanz, Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation, Circulation 102 (2000), 2118-2123.
27. D. R. Salgado, X. He, F. Su, D. B. de Sousa, L. Penaccini, L. K. Maciel, F. Taccone, J. R. Rocco, E. Silva, D. De Backer and J. L. Vincent, Sublingual microcirculatory effects of enalaprilat in an ovine model of septic shock, Shock 35 (2011), 542-549.
28. D. R. Salgado, J. R. Rocco, E. Silva and J. L. Vincent, Modulation of the renin-angiotensin-aldosterone system in sepsis: A new therapeutic approach? Expert Opin Ther Targets 14 (2010), 11-20.
29. C. R. Spillert, S. Sun, M. A. Miller and E. J. Lazaro, Hypertension-related coronary thrombosis: Prothrombic role of angiotensin II, J Natl Med Assoc 86 (1994), 686-688.
30. M. Tavares, E. Rezlan, I. Vostroknoutova, H. Khouadja and A. Mebazaa, New pharmacologic therapies for acute heart failure, Crit Care Med 36 (2008), S112-S120.
31. D. Tousoulis, H. Homaei, N. Ahmed, G. Asimakopoulos, E. Zouridakis, P. Toutouzas and G. J. Davies, Increased plasma adhesion molecule levels in patients with heart failure who have ischemic heart disease and dilated cardiomyopathy, Am Heart J 141 (2001), 277-280.
32. S. Trzeciak, R. P. Dellinger, J. E. Parrillo, M. Guglielmi, J. Bajaj, N. L. Abate, R. C. Arnold, S. Colilla, S. Zanotti and S. M. Hollenberg, Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: Relationship to hemodynamics, oxygen transport, and survival, Ann Emerg Med 49 (2007), 88-98, 98.
33. S. Trzeciak, J. V. McCoy, D. R. Phillip, R. C. Arnold, M. Rizzuto, N. L. Abate, N. I. Shapiro, J. E. Parrillo and S. M. Hollenberg, Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis, Intensive Care Med 34 (2008), 2210-2217.
34. R. M. van deWal, H. W. Plokker, D. J. Lok, F. Boomsma, F. A. van der Horst, D. J. van Veldhuisen,W. H. van Gilst and A. A. Voors, Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition, Int J Cardiol 106 (2006), 367-372.
35. J. L. Vincent, R. Moreno, J. Takala, S. Willatts, A. De Mendonca, H. Bruining, C. K. Reinhart, P. M. Suter and L. G. Thijs, The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure, On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, Intensive Care Med 22 (1996), 707-710.
36. J. B. Warren and R. K. Loi, Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins, FASEB J 9 (1995), 411-418.
37. G. Yosipovitch, J. Schneiderman, A. Erman, A. Chetrit, G. Milo, G. Boner and D. J. van Dijk, The effect of an angiotensin converting enzyme inhibitor on skin microvascular hyperaemia in microalbuminuric insulin-dependent diabetes mellitus, Diabet Med 14 (1997), 235-241.